Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

[BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF): NEUROBIOLOGY AND MARKER VALUE IN NEUROPSYCHIATRY].

Levada OA, Cherednichenko NV.

Lik Sprava. 2015 Apr-Jun;(3-4):15-25. Review. Russian.

PMID:
26827434
2.

Ovarian steroids regulate gene expression in the dorsal raphe of old female macaques.

Bethea CL, Kohama SG, Reddy AP, Urbanski HF.

Neurobiol Aging. 2016 Jan;37:179-91. doi: 10.1016/j.neurobiolaging.2015.10.004. Epub 2015 Oct 19.

3.

Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers.

Costa V, Lugert S, Jagasia R.

Handb Exp Pharmacol. 2015;228:99-155. doi: 10.1007/978-3-319-16522-6_4. Review.

PMID:
25977081
4.

Dicholine succinate, the neuronal insulin sensitizer, normalizes behavior, REM sleep, hippocampal pGSK3 beta and mRNAs of NMDA receptor subunits in mouse models of depression.

Cline BH, Costa-Nunes JP, Cespuglio R, Markova N, Santos AI, Bukhman YV, Kubatiev A, Steinbusch HW, Lesch KP, Strekalova T.

Front Behav Neurosci. 2015 Feb 26;9:37. doi: 10.3389/fnbeh.2015.00037. eCollection 2015.

5.

Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior.

Sarkar A, Chachra P, Kennedy P, Pena CJ, Desouza LA, Nestler EJ, Vaidya VA.

Neuropsychopharmacology. 2014 Aug;39(9):2221-32. doi: 10.1038/npp.2014.73. Epub 2014 Mar 25.

6.

Developmental alterations in locomotor and anxiety-like behavior as a function of D1 and D2 mRNA expression.

Falco AM, McDonald CG, Bachus SE, Smith RF.

Behav Brain Res. 2014 Mar 1;260:25-33. doi: 10.1016/j.bbr.2013.11.007. Epub 2013 Nov 14.

PMID:
24239691
7.

Chaihu-Shugan-San administration ameliorates perimenopausal anxiety and depression in rats.

Chen S, Asakawa T, Ding S, Liao L, Zhang L, Shen J, Yu J, Sugiyama K, Namba H, Li C.

PLoS One. 2013 Aug 27;8(8):e72428. doi: 10.1371/journal.pone.0072428. eCollection 2013.

8.

Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging.

Ménard C, Tse YC, Cavanagh C, Chabot JG, Herzog H, Schwarzer C, Wong TP, Quirion R.

J Neurosci. 2013 Jul 31;33(31):12792-804. doi: 10.1523/JNEUROSCI.0290-13.2013.

9.

Rapamycin suppresses brain aging in senescence-accelerated OXYS rats.

Kolosova NG, Vitovtov AO, Muraleva NA, Akulov AE, Stefanova NA, Blagosklonny MV.

Aging (Albany NY). 2013 Jun;5(6):474-84.

10.

MicroRNAs in the aging female brain: a putative mechanism for age-specific estrogen effects.

Rao YS, Mott NN, Wang Y, Chung WC, Pak TR.

Endocrinology. 2013 Aug;154(8):2795-806. doi: 10.1210/en.2013-1230. Epub 2013 May 29.

11.

Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy.

Dezsi G, Ozturk E, Stanic D, Powell KL, Blumenfeld H, O'Brien TJ, Jones NC.

Epilepsia. 2013 Apr;54(4):635-43. doi: 10.1111/epi.12118. Epub 2013 Mar 6.

12.

Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke.

Buga AM, Scholz CJ, Kumar S, Herndon JG, Alexandru D, Cojocaru GR, Dandekar T, Popa-Wagner A.

PLoS One. 2012;7(12):e50985. doi: 10.1371/journal.pone.0050985. Epub 2012 Dec 12.

13.

Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder.

Reese EA, Cheon Y, Ramadan E, Kim HW, Chang L, Rao JS, Rapoport SI, Taha AY.

Prostaglandins Leukot Essent Fatty Acids. 2012 Aug-Sep;87(2-3):71-7. doi: 10.1016/j.plefa.2012.06.003. Epub 2012 Jul 27.

14.

Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice.

Halloran J, Hussong SA, Burbank R, Podlutskaya N, Fischer KE, Sloane LB, Austad SN, Strong R, Richardson A, Hart MJ, Galvan V.

Neuroscience. 2012 Oct 25;223:102-13. doi: 10.1016/j.neuroscience.2012.06.054. Epub 2012 Jun 28. Erratum in: Neuroscience. 2015 Oct 15;306():151.

15.

The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.

Liu D, Pitta M, Lee JH, Ray B, Lahiri DK, Furukawa K, Mughal M, Jiang H, Villarreal J, Cutler RG, Greig NH, Mattson MP.

J Alzheimers Dis. 2010;22(2):443-57. doi: 10.3233/JAD-2010-101017.

16.

Conjunctivally administered NGF antibody reduces pain sensitivity and anxiety-like behavioral responses in aged female mice.

Berry A, Aloe L, Rossi S, Bonsignore LT, Capone F, Alleva E, Cirulli F.

Behav Brain Res. 2010 Jul 11;210(2):284-7. doi: 10.1016/j.bbr.2010.02.037. Epub 2010 Feb 25.

PMID:
20188766

Supplemental Content

Loading ...
Support Center